You are here

Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy

Post ASCO 2019 Lung Cancer Round Table Discussion - Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy

H. Jack West, MD, Founder, President and CEO

We are excited to share with you a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, and Founder, President and CEO Of GRACE, Charu Aggarwal, MD, MPH with the Perelman Center for Advanced Medicine, University of Pennsylvania, and Benjamin Levy MD, Clinical Director Of Medical Oncology, Assistant Professor Of Oncology at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.

The doctors recently collaborated from their respective geographical locations to review top discussion points from Lung Cancer from ASCO 2019. In this video, the doctors discuss the following: "Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy".

Please visit our community forums with any questions or comments!

Video Language:

English

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Community Forum

EGFR

Last Reply:

I don't know if you've seen it. This article and comments (no longer taking) surely can provide at least one or 2 new observations about BAC.

Are We Too Late?

Last Reply:

Very best of luck to you and your brother. Let us know if there's any way we can help.

Pancoast Tumor

Last Reply:

Hi Shannon, I'm so sorry to hear about the extensive problems you've endured. I wish we could help but we are prepared to answer questions about a diagnosed cancer and not...

6 Year Update

Last Reply:

I think you have a better understanding of how the pandemic is affecting the human psyche than the vast majority. I hope we humans come out of this better suited to...

Odd finding on shoulder X-ray

Last Reply:

Thanks so much for the quick response. Hearing the line "large mass in your scapula with probable neoplastic properties" threw me through a loop. I really expected bursitis. I'm hopeful it's...

How long can a Pleurx chest catheter stay in place?

Last Reply:

I understand Joanne. There are a million different ways to get thrown into the deep end of lung cancer and there's only so much understanding you can take in or find...

8 weeks after starting Tagrisso

Last Reply:

I hope someone with experience will chime in. According to clinicians pleurex cath can be worn as long as it's functioning appropriately but at least several months.

header share links

Logo

Main menu

You are here

Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy

Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy

Join the Conversation

Search form

Related Content

Community Forum